- Home
- BCAR vs TOI Comparison
BCAR vs TOI Comparison
Compare BCAR & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAR
- TOI
- Stock Information
- Founded
- BCAR 2025
- TOI 2007
- Country
- BCAR United States
- TOI United States
- Employees
- BCAR N/A
- TOI 825
- Industry
- BCAR Blank Checks
- TOI Medical/Nursing Services
- Sector
- BCAR Finance
- TOI Health Care
- Exchange
- BCAR Nasdaq
- TOI Nasdaq
- Market Cap
- BCAR 419.8M
- TOI 444.1M
- IPO Year
- BCAR 2025
- TOI N/A
- Fundamental
- Price
- BCAR $10.04
- TOI $4.79
- Analyst Decision
- BCAR
- TOI Strong Buy
- Analyst Count
- BCAR 0
- TOI 2
- Target Price
- BCAR N/A
- TOI $6.50
- AVG Volume (30 Days)
- BCAR 103.0K
- TOI 2.1M
- Earning Date
- BCAR 01-01-0001
- TOI 11-13-2025
- Dividend Yield
- BCAR N/A
- TOI N/A
- EPS Growth
- BCAR N/A
- TOI N/A
- EPS
- BCAR N/A
- TOI N/A
- Revenue
- BCAR N/A
- TOI $424,376,000.00
- Revenue This Year
- BCAR N/A
- TOI $21.71
- Revenue Next Year
- BCAR N/A
- TOI $20.58
- P/E Ratio
- BCAR N/A
- TOI N/A
- Revenue Growth
- BCAR N/A
- TOI 17.53
- 52 Week Low
- BCAR $9.88
- TOI $0.13
- 52 Week High
- BCAR $10.04
- TOI $4.88
- Technical
- Relative Strength Index (RSI)
- BCAR N/A
- TOI 76.11
- Support Level
- BCAR N/A
- TOI $3.47
- Resistance Level
- BCAR N/A
- TOI $4.24
- Average True Range (ATR)
- BCAR 0.00
- TOI 0.29
- MACD
- BCAR 0.00
- TOI 0.09
- Stochastic Oscillator
- BCAR 0.00
- TOI 96.47
About BCAR D. Boral ARC Acquisition I Corp. Class A Ordinary Shares
D Boral ARC Acquisition I Corp is a blank check company.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.